TSLP and atopic eczema: ADMSC-ApoVs significantly decrease the release of pro-inflammatory cytokines like interferon-γ (IFN-γ), thymic stromal lymphopoietin (TSLP), and IL-4, which are known to be elevated in atopic dermatitis.